Contrast-enhanced molecular ultrasound differentiates endoglin genotypes in mouse embryos

Abstract

Targeted ultrasound contrast imaging has the potential to become a reliable molecular imaging tool. A better understanding of the quantitative aspects of molecular ultrasound technology could facilitate the translation of this technique to the clinic for the purposes of assessing vascular pathology and detecting individual response to treatment. The objective of this study was to evaluate whether targeted ultrasound contrast-enhanced imaging can provide a quantitative measure of endogenous biomarkers. Endoglin, an endothelial biomarker involved in the processes of development, vascular homeostasis, and altered in diseases, including hereditary hemorrhagic telangiectasia type 1 and tumor angiogenesis, was the selected target. We used a parallel plate perfusion chamber in which endoglin-targeted (MBE), rat isotype IgG2 control and untargeted microbubbles were perfused across endoglin wild-type (Eng+/+), heterozygous (Eng+/-) and null (Eng-/-) embryonic mouse endothelial cells and their adhesion quantified. Microbubble binding was also assessed in late-gestation, isolated living transgenic Eng+/- and Eng+/+ embryos. Nonlinear contrast-specific ultrasound imaging performed at 21 MHz was used to collect contrast mean power ratios for all bubble types. Statistically significant differences in microbubble binding were found across genotypes for both in vitro (p<0.05) and embryonic studies (p<0.001); MBE binding was approximately twofold higher in Eng+/+ cells and embryos compared with their Eng+/- counterparts. These results suggest that molecular ultrasound is capable of reliably differentiating between molecular genotypes and relating receptor densities to quantifiable molecular ultrasound levels.

Endoglin/CD105-Based Imaging of Cancer and Cardiovascular Diseases: A Systematic Review

“…Intriguing research that is beyond the scope of this review is the work by the group of Foster, proving that endoglin-targeting microbubbles can be used to image the vasculature of living mouse embryos [ 130 , 131 ].…”

“…Intriguing research that is beyond the scope of this review is the work by the group of Foster, proving that endoglin-targeting microbubbles can be used to image the vasculature of living mouse embryos [130,131]. Besides the crucial role for angiogenesis in tumor progression, angiogenic processes are involved in multiple cardiovascular diseases, including atherosclerosis (peripheral and coronary artery disease, vein graft disease) and aortic aneurysms (both thoracic and abdominal) [132][133][134][135][136][137].…”